GALD — Galderma AG Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousLarge CapHigh Flyer

Annual balance sheet for Galderma AG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	287	234	368	457
Net Total Accounts Receivable
Net Total Receivables	732	791	766	905
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,517	1,507	1,616	1,843
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	342	401	529	577
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	12,572	12,415	12,471	12,617
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,857	1,961	1,571	1,528
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	8,024	7,946	7,102	4,827
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	4,548	4,469	5,369	7,790
Total Liabilities & Shareholders' Equity	12,572	12,415	12,471	12,617
Total Common Shares Outstanding